Extraparenchymal neurocysticercosis: Report of five cases and review of management

Juan C. Bandres, A. Clinton White, Tobias Samo, Edward C. Murphy, Richard L. Harris

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Neurocysticercosis due to parenchymal cysts carries a good prognosis regardless of therapy. Extraparenchymal neurocysticercosis (including ventricular, spinal, and subarachnoid types) carries a poorer prognosis. Most extraparenchymal cases present with hydrocephalus. Medical treatment alone in doses and schedules developed for parenchymal disease is frequently unsuccessful. For ventricular disease, most cases can be managed with shunting procedures either alone or together with the administration of antiparasitic agents (e.g., praziquantel or albendazole), without extirpation of the cysts. Subarachnoid disease was formerly associated with a case fatality rate of about 50%. However, with the combination of shunting procedures for hydroceph-alus, antiparasitic agents, and, in some cases, surgical extirpation of the cysts, the prognosis is much improved. Spinal cysticercosis can be either leptomeningeal (which responds like subarachnoid disease) or intramedullary. For all forms of neurocysticercosis, the role of antiparasitic agents needs to be better defined.

Original languageEnglish (US)
Pages (from-to)799-811
Number of pages13
JournalClinical Infectious Diseases
Volume15
Issue number5
StatePublished - Nov 1992
Externally publishedYes

Fingerprint

Neurocysticercosis
Case Management
Antiparasitic Agents
Cysts
Cysticercosis
Praziquantel
Albendazole
Hydrocephalus
Appointments and Schedules
Mortality

ASJC Scopus subject areas

  • Immunology

Cite this

Bandres, J. C., White, A. C., Samo, T., Murphy, E. C., & Harris, R. L. (1992). Extraparenchymal neurocysticercosis: Report of five cases and review of management. Clinical Infectious Diseases, 15(5), 799-811.

Extraparenchymal neurocysticercosis : Report of five cases and review of management. / Bandres, Juan C.; White, A. Clinton; Samo, Tobias; Murphy, Edward C.; Harris, Richard L.

In: Clinical Infectious Diseases, Vol. 15, No. 5, 11.1992, p. 799-811.

Research output: Contribution to journalArticle

Bandres, JC, White, AC, Samo, T, Murphy, EC & Harris, RL 1992, 'Extraparenchymal neurocysticercosis: Report of five cases and review of management', Clinical Infectious Diseases, vol. 15, no. 5, pp. 799-811.
Bandres, Juan C. ; White, A. Clinton ; Samo, Tobias ; Murphy, Edward C. ; Harris, Richard L. / Extraparenchymal neurocysticercosis : Report of five cases and review of management. In: Clinical Infectious Diseases. 1992 ; Vol. 15, No. 5. pp. 799-811.
@article{28b6ad2f3774412dabea48b0a4b70497,
title = "Extraparenchymal neurocysticercosis: Report of five cases and review of management",
abstract = "Neurocysticercosis due to parenchymal cysts carries a good prognosis regardless of therapy. Extraparenchymal neurocysticercosis (including ventricular, spinal, and subarachnoid types) carries a poorer prognosis. Most extraparenchymal cases present with hydrocephalus. Medical treatment alone in doses and schedules developed for parenchymal disease is frequently unsuccessful. For ventricular disease, most cases can be managed with shunting procedures either alone or together with the administration of antiparasitic agents (e.g., praziquantel or albendazole), without extirpation of the cysts. Subarachnoid disease was formerly associated with a case fatality rate of about 50{\%}. However, with the combination of shunting procedures for hydroceph-alus, antiparasitic agents, and, in some cases, surgical extirpation of the cysts, the prognosis is much improved. Spinal cysticercosis can be either leptomeningeal (which responds like subarachnoid disease) or intramedullary. For all forms of neurocysticercosis, the role of antiparasitic agents needs to be better defined.",
author = "Bandres, {Juan C.} and White, {A. Clinton} and Tobias Samo and Murphy, {Edward C.} and Harris, {Richard L.}",
year = "1992",
month = "11",
language = "English (US)",
volume = "15",
pages = "799--811",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Extraparenchymal neurocysticercosis

T2 - Report of five cases and review of management

AU - Bandres, Juan C.

AU - White, A. Clinton

AU - Samo, Tobias

AU - Murphy, Edward C.

AU - Harris, Richard L.

PY - 1992/11

Y1 - 1992/11

N2 - Neurocysticercosis due to parenchymal cysts carries a good prognosis regardless of therapy. Extraparenchymal neurocysticercosis (including ventricular, spinal, and subarachnoid types) carries a poorer prognosis. Most extraparenchymal cases present with hydrocephalus. Medical treatment alone in doses and schedules developed for parenchymal disease is frequently unsuccessful. For ventricular disease, most cases can be managed with shunting procedures either alone or together with the administration of antiparasitic agents (e.g., praziquantel or albendazole), without extirpation of the cysts. Subarachnoid disease was formerly associated with a case fatality rate of about 50%. However, with the combination of shunting procedures for hydroceph-alus, antiparasitic agents, and, in some cases, surgical extirpation of the cysts, the prognosis is much improved. Spinal cysticercosis can be either leptomeningeal (which responds like subarachnoid disease) or intramedullary. For all forms of neurocysticercosis, the role of antiparasitic agents needs to be better defined.

AB - Neurocysticercosis due to parenchymal cysts carries a good prognosis regardless of therapy. Extraparenchymal neurocysticercosis (including ventricular, spinal, and subarachnoid types) carries a poorer prognosis. Most extraparenchymal cases present with hydrocephalus. Medical treatment alone in doses and schedules developed for parenchymal disease is frequently unsuccessful. For ventricular disease, most cases can be managed with shunting procedures either alone or together with the administration of antiparasitic agents (e.g., praziquantel or albendazole), without extirpation of the cysts. Subarachnoid disease was formerly associated with a case fatality rate of about 50%. However, with the combination of shunting procedures for hydroceph-alus, antiparasitic agents, and, in some cases, surgical extirpation of the cysts, the prognosis is much improved. Spinal cysticercosis can be either leptomeningeal (which responds like subarachnoid disease) or intramedullary. For all forms of neurocysticercosis, the role of antiparasitic agents needs to be better defined.

UR - http://www.scopus.com/inward/record.url?scp=0026476396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026476396&partnerID=8YFLogxK

M3 - Article

C2 - 1445979

AN - SCOPUS:0026476396

VL - 15

SP - 799

EP - 811

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 5

ER -